Claudette buys ALNY 69.67: Alnylam Pharma (ALNY) Receives NoA from USPTO Covering '829 App for RNAi-Mediating, Double-Stranded Molecules
Alnylam Pharma (Nasdaq: ALNY) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the Tuschl et al. patent application 12/591,829. The â829 patent application includes newly allowed claims . ... ...
43 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home